Ingredient Guide
Butcher's Broom: Benefits, Dosage, and What the Research Says
A well-studied botanical with real clinical data behind its use for leg health and circulation support.
Written by Jessica Medson
Butcher's Broom (Ruscus aculeatus L.) is a Mediterranean shrub whose rhizome extract has been used in European phytomedicine for decades to support healthy venous circulation. Its key active compounds - the steroidal saponins ruscogenin and neoruscogenin - act on alpha-1 adrenergic receptors in vein walls to help maintain tone and reduce microvascular permeability. A 2017 systematic review and meta-analysis of 10 randomized controlled trials in 719 patients concluded that Ruscus extract is highly effective at reducing venous symptoms and edema compared to placebo, with a number needed to treat of 2.4 for leg heaviness.
What Is Butcher's Broom?
Butcher's Broom (Ruscus aculeatus L.) is a low-growing, spine-tipped evergreen shrub native to the Mediterranean basin and western Europe. Its common name comes from an old trade practice: bundles of its stiff, cladode-bearing stems were historically used by butchers to scrub and clean their wooden cutting boards.
In herbal medicine, it is the dried rhizome and root - not the stems - that carry the plant's therapeutic value. These underground portions are particularly rich in steroidal saponins, primarily ruscogenin and neoruscogenin, along with flavonoids, phenolic acids, and minor alkaloids.8 Commercial extracts are typically standardized to a defined percentage of total ruscogenins to ensure consistency between products.
The plant has a long history in European traditional medicine as a circulatory tonic. Germany's Commission E approved a Butcher's Broom rhizome extract monograph for the supportive treatment of chronic venous insufficiency and hemorrhoidal complaints - one of a small number of herbal ingredients to receive this level of formal regulatory recognition in Europe. In the United States, it is sold as a dietary supplement under DSHEA and is not approved to diagnose, treat, cure, or prevent any disease.
Clinical research has focused almost exclusively on a standardized combination product called Cyclo 3 Fort, which pairs Ruscus extract with hesperidin methyl-chalcone (HMC) and ascorbic acid. This means most human evidence reflects the combination rather than Ruscus alone - an important nuance to keep in mind when evaluating the data.8
How Does It Work? The Mechanisms Behind the Research
Butcher's Broom exerts its vascular effects through two primary, complementary pathways that have been characterized in pharmacological studies.
Alpha-adrenergic venoconstriction
The saponins in Ruscus extract - particularly ruscogenin - bind to alpha-1 adrenergic receptors on smooth muscle cells in vein walls, causing them to contract. This venoconstricting action increases vein wall tone, which helps reduce the pooling of blood in the lower limbs that contributes to heaviness, swelling, and discomfort. Preclinical work in isolated canine saphenous veins confirmed that the alpha-1 adrenergic component dominates the contractile response to Ruscus extract, and that the response is temperature-dependent: warming augments it while cooling inhibits it.7 This mechanism is categorized as Tier C (animal data) and serves as the pharmacological rationale for observed human clinical effects.
Reduction of microvascular permeability
Beyond direct venoconstriction, Ruscus extract dose-dependently reduces the leakage of fluid and macromolecules across capillary walls. Research in an animal model of histamine-induced microvascular permeability found that Ruscus extract inhibited fluid extravasation through an alpha-1 adrenoceptor and calcium-dependent mechanism.6 In plain terms, the extract may help keep fluid inside blood vessels rather than allowing it to accumulate in surrounding tissue - the process that leads to visible leg and ankle swelling.
Together, these two mechanisms - increased vein wall tone and tighter capillary barriers - provide the biological rationale for the clinical findings in chronic venous insufficiency and edema reduction trials.
The flavonoid co-formulation (hesperidin) likely contributes additional anti-inflammatory and capillary-stabilizing effects, which is why most commercial preparations and most clinical trials combine both ingredients.
Venous Circulation Support: What the Research Shows
Chronic venous insufficiency (CVI) is a condition in which vein valves in the legs fail to keep blood moving efficiently toward the heart, leading to symptoms such as leg heaviness, aching, swelling, and feelings of tension. This is where Butcher's Broom has its strongest and most consistent body of human clinical evidence.
What the research shows
A 2017 systematic review and meta-analysis by Kakkos and Allaert pooled data from 10 randomized, double-blind, placebo-controlled trials enrolling 719 patients.1 Compared to placebo, Ruscus-based formulations produced statistically significant reductions across all measured outcomes:
- Leg pain: relative risk 0.35, number needed to treat (NNT) = 5
- Leg heaviness: relative risk 0.26, NNT = 2.4 (meaning roughly 1 in 2-3 treated patients experienced meaningful relief that placebo did not provide)
- Paresthesia (tingling/pins-and-needles): relative risk 0.27, NNT = 1.8
- Feeling of swelling: relative risk 0.53, NNT = 4
Objective measurements also improved: ankle circumference decreased (standardized mean difference -0.74) and leg or foot volume decreased (SMD -0.61).1 The authors characterized the level of evidence as high-quality, based on the randomized, double-blind, placebo-controlled design of the included trials.
One well-designed individual trial bears highlighting. Vanscheidt and colleagues enrolled 166 women with CVI in a 12-week double-blind RCT comparing a standardized Ruscus extract to placebo.2 Among the 148 patients analyzed, the Ruscus group showed a leg volume reduction of 20.5 ml at 12 weeks versus placebo, alongside significant improvements in subjective symptoms including heavy/tired legs and tension sensations. Tolerability was rated as good or very good by the vast majority of participants.
An earlier crossover study in 40 patients by Cappelli and colleagues found that plethysmographic parameters - objective measures of venous blood pooling - improved significantly during active Ruscus treatment periods versus placebo.5
In a 124-patient prospective study, initial rates of leg pain (79%), heaviness (85%), cramps (74%), and edema (82%) each fell dramatically within 2 weeks of treatment with a Ruscus/HMC/ascorbic acid combination: to 20%, 12%, 8%, and 14% respectively.3 This was an open-label design without a control arm, so placebo effects cannot be excluded.
Bottom line: Clinical research suggests that standardized Ruscus extract - typically in combination with hesperidin - may help maintain comfortable leg sensations and support healthy lower-limb circulation in people with venous insufficiency. The body of evidence, while largely tied to a specific formulation, is among the more robust available for any botanical in this category.
Edema Reduction and Lymphatic Support
The same mechanisms that help support vein wall tone may also help limit the fluid leakage that causes tissue swelling. Several trials have specifically measured edema and lymphatic outcomes.
What the research shows
A randomized, double-blind, placebo-controlled trial by Cluzan and colleagues enrolled 57 patients with secondary upper-limb lymphedema following breast cancer treatment.4 After 3 months of Cyclo 3 Fort (Ruscus extract plus HMC), the reduction in arm edema volume was 12.9% greater than with placebo (p = 0.009). Forearm edema responded better than upper-arm edema, and the treatment was well tolerated with minimal adverse reactions.
The 2017 meta-analysis confirmed objective ankle circumference and leg volume reductions across pooled RCT data.1 A comparative open-label study in 80 patients with chronic venous-lymphatic insufficiency found that Cyclo 3 Fort produced limb size reductions that persisted at 90 days (p less than 0.01), whereas the comparator (hydroxyethyl rutoside) did not maintain the same level of improvement at that time point.9
Important caveat: Most of these studies used the three-ingredient combination product, and it is not possible to determine how much of the edema reduction is attributable to Ruscus versus hesperidin or ascorbic acid individually. Ruscus extract as a standalone agent has not been as rigorously studied for edema in modern RCTs.
Other Areas of Research: Orthostatic Hypotension and Hemorrhoidal Complaints
Two additional applications have attracted research interest, though the evidence base is considerably weaker than for CVI.
Orthostatic hypotension
Orthostatic hypotension - a drop in blood pressure upon standing - is a challenging condition affecting elderly and autonomic-dysfunction patients. Because Butcher's Broom causes venoconstriction, it theoretically reduces peripheral venous pooling and may help maintain blood pressure on standing. A review article proposed Ruscus aculeatus as a potential supportive option, describing its mechanism and presenting a case report of a patient who experienced benefit.10 This remains Tier C evidence (a single case report plus mechanistic rationale). No adequately powered RCT has tested Ruscus for orthostatic hypotension as of this writing.
Hemorrhoidal complaints
Germany's Commission E monograph includes hemorrhoidal complaints as a traditional indication, and Butcher's Broom has been investigated in European proctology literature.8 The rationale is the same venoconstrictive mechanism: hemorrhoidal tissue is a specialized vascular plexus, and increasing vein wall tone may help reduce hemorrhoid engorgement and associated discomfort. However, modern placebo-controlled trials specifically designed for hemorrhoidal disease are limited, and the existing human data does not meet the threshold for a strong efficacy claim. People experiencing hemorrhoidal symptoms should consult a healthcare provider.
Safety, Side Effects, and Interactions
Who should avoid Butcher's Broom:
- Pregnancy and breastfeeding: Adequate safety data are not available. Butcher's Broom should not be used during pregnancy or while nursing without explicit guidance from a qualified healthcare provider.
- Uncontrolled hypertension: Because the primary mechanism is vasoconstriction, the extract has the potential to raise blood pressure. People with uncontrolled or poorly controlled hypertension should avoid this ingredient.
- Benign prostatic hyperplasia (BPH): Alpha-adrenergic agonist activity may theoretically worsen urinary retention in men with BPH. Consult a healthcare provider before use.
Potential drug interactions:
- Antihypertensive medications: The vasoconstrictive properties of Ruscus extract may antagonize the blood-pressure-lowering effects of calcium channel blockers, ACE inhibitors, beta-blockers, and other antihypertensives. Monitor blood pressure closely if combining these.
- Diabetes medications: A 2025 comprehensive review flagged a case report of diabetic ketoacidosis occurring in a patient using Ruscus extract alongside metformin.8 While a single case report cannot establish causation, individuals with diabetes managing blood glucose with medications should discuss use with their prescribing clinician.
- MAO inhibitors and sympathomimetics: Theoretical additive vasoconstrictor effects have not been formally studied but are a reasonable theoretical concern.
Observed adverse effects in clinical trials: In the 12-week Vanscheidt RCT, 22 adverse events were reported in the 148-patient Ruscus group, but only 1 was considered possibly related to the medication.2 The most commonly described adverse effects across the literature are mild gastrointestinal complaints (nausea, upset stomach). Allergic reactions to ruscogenins have been reported rarely.
Toxicological data gaps: As the 2025 Pacuła review notes, pharmacokinetic and long-term toxicological data for Ruscus extract and its saponins remain incomplete.8 Most trials lasted 8-12 weeks, and there is limited data on safety beyond 3 months.
This is not a complete list of warnings or interactions. Always disclose all supplements to your prescribing healthcare team.
Butcher's Broom: Doses Used in Clinical Research
Clinical trials have used standardized Ruscus extract in combination with hesperidin methyl-chalcone (HMC) and ascorbic acid. Doses below reflect the Ruscus extract component as used in the most-cited trials. No trials have established a single-ingredient Ruscus optimal dose for standalone use in rigorous RCTs.
| Goal | Typical Dose | Timing | Notes |
|---|---|---|---|
| Chronic venous insufficiency (leg heaviness, swelling, aching) | Standardized extract providing 7-11 mg total ruscogenins per day, divided across 2-3 capsules | With meals | Dose range cited in the German Commission E monograph; used in Vanscheidt 2002 RCT (PMID 12040966) over 12 weeks |
| Edema and CVI symptom reduction (combination studies) | 150 mg Ruscus dry extract + 150 mg HMC + 100 mg ascorbic acid, twice daily | Morning and evening with food | Dose used in Aguilar Peralta 2007 (PMID 18091707) and Guex 2009/2010 quality-of-life studies; most data involves this 3-ingredient formula |
| Secondary lymphedema support (post-breast cancer) | Same combination as above (Cyclo 3 Fort equivalent), twice daily | Morning and evening | Used in Cluzan 1996 RCT (PMID 8721977) over 3 months; 12.9% edema volume reduction vs placebo (p=0.009) |
These doses are derived from published clinical research and are not a prescription or medical recommendation. Consult a healthcare provider before starting any new supplement, especially if you take medications or have a chronic health condition.
What the Evidence Shows at a Glance
Summary of outcomes studied in human clinical research on standardized Ruscus aculeatus extract (alone or in combination with hesperidin and vitamin C).
| Outcome | What studies show | Strength of evidence |
|---|---|---|
| Leg heaviness in CVI | Significant reduction vs placebo; NNT = 2.4 across 10 RCTs (N=719) | Tier A - Multiple RCTs + meta-analysis |
| Leg pain in CVI | Significant reduction vs placebo; NNT = 5 across pooled RCT data | Tier A - Multiple RCTs + meta-analysis |
| Ankle circumference / leg volume | Objective reductions confirmed; SMD -0.74 for ankle, -0.61 for leg volume | Tier A - Multiple RCTs + meta-analysis |
| Tingling / paresthesia | Significant reduction vs placebo; NNT = 1.8 in meta-analysis | Tier A - Meta-analysis |
| Secondary lymphedema (post-cancer) | 12.9% greater reduction in arm edema volume vs placebo at 3 months (p=0.009) | Tier A - Single RCT (N=57) |
| Quality of life in CVI | SF-12 and CIVIQ scores improved significantly in 917 patients over 12 weeks | Tier B - Large observational cohort |
| Orthostatic hypotension | Mechanistically plausible; supported by 1 case report only | Tier C - Case report + preclinical |
| Hemorrhoidal complaints | Traditional indication; Commission E approved; controlled trial data very limited | Tier C - Traditional use / limited RCT data |
Tier A = human RCT or meta-analysis. Tier B = human observational or open-label study. Tier C = animal, cell, or single case-report data only. Most Tier A evidence involves the combination formula (Ruscus + hesperidin + vitamin C), not Ruscus alone.
Frequently Asked Questions
What is Butcher's Broom good for?
Butcher's Broom is best studied for supporting healthy venous circulation in the legs. A 2017 meta-analysis of 10 randomized trials found it significantly reduced leg heaviness, pain, tingling, and ankle swelling compared to placebo. Traditional uses also include hemorrhoidal complaints, though controlled trial evidence for that indication is limited.
How much Butcher's Broom should I take?
Clinical trials and the German Commission E monograph support doses providing 7 to 11 mg of total ruscogenins per day, typically divided across 2 to 3 capsules taken with meals. Most trials used Ruscus extract in combination with hesperidin and vitamin C rather than as a standalone ingredient. Follow your product's label and consult a healthcare provider.
Is Butcher's Broom safe?
In clinical trials of up to 12 weeks, Butcher's Broom was generally well-tolerated, with only mild and infrequent side effects such as nausea. It should be avoided during pregnancy, by those with uncontrolled high blood pressure, and by people taking antihypertensive or diabetes medications without medical supervision. Long-term safety data beyond 3 months are limited.
Does Butcher's Broom actually work for leg swelling?
Yes, within the studied population, it produced meaningful results. The 2017 meta-analysis (10 RCTs, 719 patients) showed statistically significant reductions in ankle circumference and leg volume. A separate randomized trial in 57 lymphedema patients found a 12.9% greater reduction in arm swelling versus placebo after 3 months (p=0.009). Most evidence involves combination formulas.
What are the side effects of Butcher's Broom?
The most commonly reported side effects are mild gastrointestinal symptoms such as nausea or stomach upset. In a 12-week RCT of 148 patients, only 1 adverse event out of 22 reported was considered possibly related to the Ruscus extract. Rare allergic reactions to ruscogenins have been documented. Blood pressure elevation is a theoretical concern given its vasoconstrictive mechanism.
Can Butcher's Broom help with varicose veins?
Butcher's Broom does not physically remove or collapse varicose veins. Clinical research supports its ability to reduce associated symptoms - leg heaviness, aching, and swelling - by improving vein wall tone and reducing fluid leakage from capillaries. It is categorized as a supportive (phlebotonic) approach, not a structural treatment.
Can Butcher's Broom raise blood pressure?
Theoretically, yes. Ruscus extract works partly by activating alpha-1 adrenergic receptors to constrict vein walls - the same receptor class involved in blood pressure regulation. People with hypertension or those taking blood pressure medications should consult a physician before use. Clinical trial safety reporting has not highlighted this as a frequent real-world event at standard doses.
Can I take Butcher's Broom if I am pregnant?
No. Sufficient safety data during pregnancy and breastfeeding have not been established. The vasoconstrictive properties of ruscogenins raise theoretical concerns about reduced placental blood flow. Butcher's Broom should not be used during pregnancy or while nursing without explicit advice from a qualified healthcare provider.
How long does it take for Butcher's Broom to work?
In open-label clinical studies, participants reported reductions in leg pain, heaviness, and edema within 2 weeks of starting a combination Ruscus formula. In placebo-controlled RCTs, statistically significant improvements in leg volume were observed at 8 and 12 weeks. Individual response times will vary based on the severity of the underlying condition and the formulation used.
Is Butcher's Broom the same as horse chestnut?
No. Both are botanical supplements studied for venous health, but they are entirely different plants with different active compounds and mechanisms. Butcher's Broom (Ruscus aculeatus) contains steroidal saponins (ruscogenins) and works via alpha-adrenergic venoconstriction. Horse chestnut (Aesculus hippocastanum) contains the triterpenoid aescin and works primarily by reducing capillary permeability and inhibiting inflammatory enzymes.
Shop Butcher's Broom
HealthFare Butcher's Broom supplements
Scientific References
- 1.Kakkos SK, Allaert FA Efficacy of Ruscus extract, HMC and vitamin C, constituents of Cyclo 3 fort, on improving individual venous symptoms and edema: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials. International Angiology. 2017. PubMed: 28225220Clinical (RCT / meta-analysis)
- 2.Vanscheidt W, Jost V, Wolna P, Lucker PW, Muller A, Theurer C, Patz B, Grutzner KI Efficacy and safety of a Butcher's broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency. Arzneimittelforschung. 2002. PubMed: 12040966Clinical (RCT / meta-analysis)
- 3.Aguilar Peralta GR, Arevalo Gardoqui J, Llamas Macias FJ, Navarro Ceja VH, Mendoza Cisneros SA, Martinez Macias CG Clinical and capillaroscopic evaluation in the treatment of chronic venous insufficiency with Ruscus aculeatus, hesperidin methylchalcone and ascorbic acid in venous insufficiency treatment of ambulatory patients. International Angiology. 2007. PubMed: 18091707Human observational
- 4.Cluzan RV, Alliot F, Ghabboun S, Pascot M Treatment of secondary lymphedema of the upper limb with CYCLO 3 FORT. Lymphology. 1996. PubMed: 8721977Clinical (RCT / meta-analysis)
- 5.Cappelli R, Nicora M, Di Perri T Use of extract of Ruscus aculeatus in venous disease in the lower limbs. Drugs under Experimental and Clinical Research. 1988. PubMed: 3048951Clinical (RCT / meta-analysis)
- 6.Bouskela E, Cyrino FZ, Marcelon G Possible mechanisms for the inhibitory effect of Ruscus extract on increased microvascular permeability induced by histamine in hamster cheek pouch. Journal of Cardiovascular Pharmacology. 1994. PubMed: 7526061Preclinical (animal / cell)
- 7.Rubanyi G, Marcelon G, Vanhoutte PM Effect of temperature on the responsiveness of cutaneous veins to the extract of Ruscus aculeatus. General Pharmacology. 1984. PubMed: 6150876Preclinical (animal / cell)
- 8.Pacula AJ et al. Current Insights into the Phytochemistry and Pharmacological Properties of Ruscus aculeatus. Molecules. 2025. PubMed: 41302473Human observational
- 9.Beltramino R, Penenory A, Buceta AM An open-label, randomised multicentre study comparing the efficacy and safety of CYCLO 3 FORT versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency. International Angiology. 1999. PubMed: 10811525Human observational
- 10.Redman DA Ruscus aculeatus (butcher's broom) as a potential treatment for orthostatic hypotension, with a case report. Journal of Alternative and Complementary Medicine. 2000. PubMed: 11152059Preclinical (animal / cell)
- 11.Guex JJ, Avril L, Enrici E, Enriquez E, Lis C, Taieb C Quality of life improvement in Latin American patients suffering from chronic venous disorder using a combination of Ruscus aculeatus and hesperidin methyl-chalcone and ascorbic acid (quality study). International Angiology. 2010. PubMed: 21173734Human observational
- 12.Guex JJ, Enriquez Vega DM, Avril L, Boussetta S, Taieb C Assessment of quality of life in Mexican patients suffering from chronic venous disorder - impact of oral Ruscus aculeatus-hesperidin-methyl-chalcone-ascorbic acid treatment. Phlebology. 2009. PubMed: 19620698Human observational